ACTACEL
 |
|
|
Package:
VIAL (suspension for injection): 1 + 1 x 0.5 ml
Dosage:
Primary immunization is begun at the age of 2 months and comprises 3 doses of 0.5 ml each, at intervals of one or two months followed by a booster dose administered one year after the primary immunization. I.M. route. See prescribing information for full details.
Prescribing Restrictions: None
Indications:
Primary vaccination of infants at or above the age of 2 months and as a booster in children up to their 6th birthday against diphtheria, tetanus, pertussis and invasive Hemophilus influenza type B infection.
Contra-Indications:
Severe febrile illness, acute infection, allergy to component, anaphylactic or other allergic reaction to a previous dose, a history of hypotonic-hyporesponsive episodes, children after their sixth birthday or to adolescents or adults.
Special Precautions:
See prescribing information for full details.
Side Effects:
Fever, irritability, inconsolable crying, drowsiness, decreased feeding. Redness, tenderness, swelling at the vaccination site. See prescribing information for full details.
Drug Interactions:
If used in persons with malignancies, receiving immunosuppressive therapies, including corticosteroids, irradiation, antimetabolites, alkylating agents, cytotoxic drugs, or who are otherwise immunocompromised (including HIV infected individuals), the expected immune response may not be obtained.
